Navigation Links
Use of Morning-After Pill on the Rise: CDC
Date:2/14/2013

By Steven Reinberg
HealthDay Reporter

THURSDAY, Feb. 14 (HealthDay News) -- The number of U.S. women using the "morning-after" contraception pill has risen dramatically in the last decade, federal health officials report.

According to the Centers for Disease Control and Prevention, about 4.2 percent of women in 2002 said they had used the pill, but between 2006 and 2010 that figure had jumped to 11 percent, which translates to 5.8 million women who were between 15 and 44 years old.

The pill, considered emergency contraception to prevent unwanted pregnancy, was particularly popular among young women between 20 and 24 years old, who accounted for 23 percent of users, the government report found.

The report, released Wednesday by the CDC's National Center for Health Statistics using data from the 2006-2010 National Survey of Family Growth, also found:

  • Non-Hispanic white and Hispanic women were more likely to have used emergency contraception, 11 percent, compared with non-Hispanic black women, 7.9 percent.
  • 16 percent of users were between the ages of 25 to 29, 14 percent were teens 15 to 19 years old, and only 5 percent were 30 or older.
  • 19 percent of the women who used the pill weren't married, and 14 percent lived with a partner.
  • The most common reasons for using the pill were a woman's fear that the contraceptive she was using might not work, or because she had unprotected sex.
  • Most of the women who took the morning-after pill had used it only once; 24 percent used it twice, and 17 percent had used it at least three times.

Emergency contraception is a high dose of progestin that prevents pregnancy by delaying ovulation (when the egg leaves the ovary and travels into the fallopian tube where it's available for fertilization by sperm). Some research suggests emergency contraception may make it more difficult for sperm to get past the cervix and into the uterus, and may make the uterus less hospitable to sperm.

Although the morning-after pill can be taken up to five days after unprotected sex, it becomes less effective the longer women wait.

The new report is likely to buttress the Obama administration's goal of providing contraception to all women, which has pitted the administration against religious and conservative groups that oppose any form of birth control.

Dr. Jill Rabin, chief of ambulatory care obstetrics and gynecology and head of urogynecology at Long Island Jewish Medical Center in New Hyde Park, N.Y., believes the increased use of the morning-after pill has to do with its longevity and because it has been proven safe and effective.

"It's safer than aspirin," she said.

She also disputes the claim by some conservative groups who see the pill as an abortion pill. "It is definitely not an abortion pill. Once an egg is fertilized, the pill has no power," she said.

"It is far better to prevent an unintended pregnancy if a woman is not ready to conceive," Rabin added.

Planned Parenthood also applauded the new findings, saying the morning-after pill is key to providing women with a choice.

"These data underscores what we see at Planned Parenthood health centers every day -- that birth control is central to women's health and that they must have access to a full range of methods," Deborah Nucatola, senior director of medical services at the Planned Parenthood Federation of America, said in a statement.

"Previous studies also show that emergency contraception is safe for women of all ages and that rates of unprotected sex do not increase when teens have easier access to emergency contraception," she added.

According to Planned Parenthood, the morning-after pill is available in drug stores without a prescription for those 17 and older. For women under 17, a doctor's prescription is needed.

The cost of emergency contraception varies, running anywhere from $10 to $70. For women who need a prescription, the cost of the pill and the doctor visit can be as high a $250, according to Planned Parenthood.

More information

Princeton University has more on emergency contraception.

SOURCES: Jill Rabin, M.D., chief, ambulatory care, obstetrics and gynecology, and head, urogynecology, Long Island Jewish Medical Center, New Hyde Park, N.Y.; Deborah Nucatola, senior director of medical services, Planned Parenthood Federation of America; U.S. Centers for Disease Control and Prevention, National Center for Health Statistics, report, Use of Emergency Contraception Among Women Aged 15-44," February 2013


'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Heavy Smokers Cut Back the Most When Cigarette Taxes Rise: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: